Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Methods of reducing fever

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advancing perovskite photocatalysis: synergistic effect of Nd/Mn co-doping and CNTs integration for water treatment.

RSC advances·2026

Same author

Cerium-modified niobium oxide/reduced graphene oxide (Ce-Nb<sub>2</sub>O<sub>5</sub>/r-GO) hybrid: advances in charge transport dynamics for photocatalytic applications.

RSC advances·2026

Same author

Mn<sub>3</sub>O<sub>4</sub>/biochar catalyst for enhanced PMS activation and antibiotic degradation <i>via</i> radical and non-radical pathways.

RSC advances·2026

Same author

Multifunctional Ag-doped CuS surface nanostructures for simultaneous dye degradation and bacterial inactivation <i>via</i> visible-light activation.

RSC advances·2026

Same author

Empowering solar-driven degradation: advancements in lanthanum-doped Bi<sub>2</sub>O<sub>3</sub>/g-C<sub>3</sub>N<sub>4</sub> heterojunctions for high-performance photocatalysis.

RSC advances·2026

Same author

Performance-optimized N-doped CrCo<sub>2</sub>O<sub>4</sub> nanoferrite integrated with CNTs: a high-performance photocatalyst for next-generation wastewater remediation.

RSC advances·2026

Search research articles

Related Experiment Video

Updated: Feb 27, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

Fighting the Dengue Virus.

Aniqa Faraz¹, Muhammad Aadil², Muhammad Nabeel Shafqat³

¹Department of Internal Medicine, King Edward Medical University Lahore, Pakistan.

|June 28, 2017

Summary

Dengue incidence is rising globally, affecting a third of the world population. A new dengue vaccine offers hope for disease management, despite potential limitations, with correct use being key.

Keywords:

dengue vaccine dengue virus

More Related Videos

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination

Published on: July 4, 2007

Related Experiment Videos

Last Updated: Feb 27, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination

Published on: July 4, 2007

Area of Science:

Tropical medicine
Vaccinology
Epidemiology

Background:

Dengue incidence has significantly increased globally over the past decade.
The disease affects approximately one-third of the world's population in endemic regions.
Current control measures have shown limited success in reducing dengue prevalence.

Discussion:

The development of a dengue vaccine represents a significant advancement in combating the disease.
The vaccine has potential limitations and risks that need careful consideration.
Proper administration and usage protocols are crucial for maximizing the vaccine's benefits.

Key Insights:

The dengue vaccine holds revolutionary potential for future patient management.
Careful evaluation of the vaccine's benefits versus risks is essential.
Optimizing the use of the dengue vaccine is paramount for effective disease control.

Outlook:

The dengue vaccine could become a cornerstone in dengue management strategies.
Further research and clinical data are needed to fully understand the vaccine's long-term impact.
Successful integration of the vaccine into public health programs will be critical.